—

TCG Crossover Management, LLC

Q1 2026 13F Holdings

  • Location
    palo alto, CA
  • Num holdings

    49

  • Value ($000)

    $3,495,391

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001839948
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

ABIVAX SA AMERICAN DEPOSITARY SHARES

ADRS
00370M103
$721.67M
21 %

6,481,085

C
CGON

CG ONCOLOGY INC

COMM
156944100
$248.4M
7 %

3,670,206

T
TNGX

TANGO THERAPEUTICS INC

COMM
87583X109
$220.31M
6 %

10,531,071

C
COGT

COGENT BIOSCIENCES INC

COMM
19240Q201
$190.41M
5 %

4,946,894

C
CNTA

CENTESSA PHARMACEUTICALS PLC

ADRS
152309100
$170.26M
5 %

4,286,480

D
DNTH

DIANTHUS THERAPEUTICS INC

COMM
252828108
$140.7M
4 %

1,676,624

---

TYRA BIOSCIENCES INC

COMM
90240B106
$124.44M
4 %

3,248,980

I
IMVT

IMMUNOVANT INC

COMM
45258J102
$110.74M
3 %

4,457,988

B
BCRX

BIOCRYST PHARMACEUTICALS INC

COMM
09058V103
$104.92M
3 %

11,020,968

M
MIRM

MIRUM PHARMACEUTICALS INC

COMM
604749101
$98.11M
3 %

1,062,049

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 49